Internal tandem duplication (ITD) mutations in the Fms-related tyrosine kinase 3 (FLT3) gene (FLT3-ITD) are found in 20–30% of patients with acute myeloid leukemia (AML) and are associated with a poor prognosis [20,21]. This evidence concerns the gene FLT3 and acute myeloid leukemia.